GoodRx (GDRX)
(Delayed Data from NSDQ)
$6.97 USD
+0.35 (5.29%)
Updated Apr 23, 2024 03:59 PM ET
After-Market: $6.96 -0.01 (-0.14%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth F Momentum D VGM
Cash flow Statements
Fiscal Year End for GoodRx Holdings, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -8.87 | -32.83 | -25.25 | -293.62 | 66.05 |
Depreciation/Amortization & Depletion | 111.05 | 57.59 | 37.98 | 21.82 | 16.95 |
Net Change from Assets/Liabilities | -20.58 | -20.29 | -11.80 | -32.46 | -4.82 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 56.69 | 142.31 | 177.85 | 435.60 | 5.10 |
Net Cash From Operating Activities | 138.29 | 146.78 | 178.78 | 131.34 | 83.29 |
Property & Equipment | -55.77 | -55.21 | -34.46 | -35.82 | -5.75 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -140.28 | -140.27 | -55.79 | -31.31 |
Investments | 0.00 | -15.01 | -4.01 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -55.77 | -210.50 | -178.73 | -91.62 | -37.06 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -96.64 | -92.56 | 35.02 | 992.87 | 4.67 |
Issuance (Repayment) of Debt | -5.27 | -7.03 | -7.03 | -7.03 | -57.23 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -65.48 | -20.64 | -58.52 | -80.02 | -2.21 |
Net Cash from Financing Activities | -167.40 | -120.23 | -30.53 | 905.82 | -54.78 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -84.87 | -183.94 | -30.48 | 945.54 | -8.55 |
Cash at Beginning of Period | 757.17 | 941.11 | 971.59 | 26.05 | 34.60 |
Cash at End of Period | 672.30 | 757.17 | 941.11 | 971.59 | 26.05 |
Diluted Net EPS | -0.02 | -0.08 | -0.06 | -1.07 | 0.18 |
Fiscal Year End for GoodRx Holdings, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -8.87 | 17.00 | 55.50 | -3.29 |
Depreciation/Amortization & Depletion | NA | 111.05 | 66.60 | 32.73 | 15.79 |
Net Change from Assets/Liabilities | NA | -20.58 | 5.75 | -10.35 | -8.59 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 56.69 | 33.07 | -15.72 | 28.38 |
Net Cash From Operating Activities | NA | 138.29 | 122.42 | 62.15 | 32.29 |
Property & Equipment | NA | -55.77 | -42.89 | -29.25 | -14.29 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -55.77 | -42.89 | -29.25 | -14.29 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | -96.64 | -21.12 | -16.52 | -8.81 |
Issuance (Repayment) of Debt | NA | -5.27 | -5.27 | -3.52 | -1.76 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -65.48 | -15.40 | -8.05 | -3.52 |
Net Cash from Financing Activities | NA | -167.40 | -41.79 | -28.08 | -14.09 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -84.87 | 37.74 | 4.82 | 3.91 |
Cash at Beginning of Period | NA | 757.17 | 757.17 | 757.17 | 757.17 |
Cash at End of Period | NA | 672.30 | 794.91 | 761.99 | 761.08 |
Diluted Net EPS | NA | -0.06 | -0.09 | 0.14 | -0.01 |